Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases,... Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.005 | -16.6666666667 | 0.03 | 0.035 | 0.025 | 100827 | 0.03 | CS |
| 4 | -0.005 | -16.6666666667 | 0.03 | 0.035 | 0.025 | 210043 | 0.03051461 | CS |
| 12 | -0.02 | -44.4444444444 | 0.045 | 0.05 | 0.025 | 206907 | 0.03425174 | CS |
| 26 | 0.01 | 66.6666666667 | 0.015 | 0.08 | 0.01 | 433601 | 0.03806973 | CS |
| 52 | 0.005 | 25 | 0.02 | 0.08 | 0.005 | 361815 | 0.02944111 | CS |
| 156 | -0.02 | -44.4444444444 | 0.045 | 0.08 | 0.005 | 327143 | 0.02397802 | CS |
| 260 | -0.575 | -95.8333333333 | 0.6 | 0.65 | 0.005 | 353870 | 0.14812772 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
